About us: ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, we balance knowledge of what works with a vision for what’s next, so we can adapt without compromising standards. Powered by the company’s EXPERT® technology platform, our solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. In 2017, more than 60% of all FDA drug approvals came from ERT-supported studies. Pharma companies, Biotechs, and CROs have relied on ERT solutions in over 13,000 studies spanning more than three million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly – and with confidence.

United States



Trial Oversight Site Optimization Patient Engagement Safety & Efficacy: eCOA/ePRO Solutions, Suicide Risk Assessment, Respiratory and Cardiac Safety: Diagnostics & Home Monitoring, Clinical Consulting Safety & Efficacy: eCOA/ePRO Solutions, Imaging, Respiratory and Cardiac Safety: Diagnostics & Home Monitoring, Clinical Consulting

View Employees

Ryan Kennedy
Product Manager, Healthcare at ERT
Drew Bustos
Head of Corporate Strategy & Market Research at ERT
Matthew Steel
Associate Director Business Development at ERT
Tomi Soremekun
ECG Specialist at ERT
Catherine Saki
Business Development Director Europe at ERT
David Elario
EVP Operations & Delivery at ERT
Susan LoPiccolo
Director, Cardiac Sales at ERT
Virginia Bell
Lead Quality Control Test Engineer, Products at ERT
Rachel Page
VP Strategic Partnerships at ERT
Patricia Radzewicz
cardiac safety specialist at ERT

Find more contacts